Direct enantiospecific HPLC bioanalysis of (R,S)‐atenolol on a chiral stationary phase | Zendy

Kofahl Birgit | Zendy; Henke Dorit | Zendy; Mutschler Ernst | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Direct enantiospecific HPLC bioanalysis of (R,S)‐atenolol on a chiral stationary phase

Author(s) -

Kofahl Birgit,

Henke Dorit,

Mutschler Ernst

Publication year - 1993

Publication title -

chirality

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.43

H-Index - 77

eISSN - 1520-636X

pISSN - 0899-0042

DOI - 10.1002/chir.530050614

Subject(s) - chemistry , enantiomer , chromatography , bioanalysis , atenolol , chiral stationary phase , high performance liquid chromatography , chiral column chromatography , urine , pharmacokinetics , silica gel , dichloromethane , pindolol , organic chemistry , pharmacology , solvent , receptor , medicine , biochemistry , blood pressure , radiology

The simultaneous determination of the enantiomers of the β 1 ‐selective adrenergic antagonist atenolol in human plasma and urine is described. After an alkaline preextraction atenolol is extracted from biological material at pH 12.3 using dichloromethane/propan‐2‐ol. The separation of the underivatized enantiomers is achieved by high‐performance liquid chromatography on a chiral stationary phase (Chiralcel OD, cellulose tris‐3, 5‐dimethylphenylcarbamate, coated on silica gel) with fluorimetric detection. (−)‐(S)‐Pindolol is used as an internal standard. The detection limits of 5 ng/ml enantiomer in plasma and 50 ng/ml enantiomer in urine are sufficient for pharmacokinetic studies after therapeutic doses. © 1993 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research